Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Harley-Davidson Inc (HOG) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Harley-Davidson IncTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Harley-Davidson Inc vs Intuitive Surgical, Inc. — how do they compare? Harley-Davidson Inc trades at $26.84 (market cap $2.78B), while Intuitive Surgical, Inc. trades at $426.69 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 52.8× Harley-Davidson Inc's market cap, and Harley-Davidson Inc pays a 2.8% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Harley-Davidson Inc for 92 Days and Intuitive Surgical, Inc. for 84 Days on average.

HOGISRG
Market Cap
$2.78B$146.76B
Volume
2,966,3892,529,814
Sector
Consumer CyclicalHealth
52-Week High
$28.46$592.85
52-Week Low
$17.19$332.02
Typical Hold Time
92 Days84 Days
Enterprise Value
$3.20B$141.54B
Dividend Yield
2.8%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Harley-Davidson Inc

Harley-Davidson (HOG) trades at $26.83, down 0.45% with a bullish technical signal and mixed earnings performance. The stock shows attractive valuation metrics with P/E of 14.86 and P/S of 0.72, while revenue has declined from $5.8B in 2022 to $4.5B in 2025. Recent Q2 2026 earnings beat expectations with $0.75 EPS versus $0.645 expected, though Q1 and Q4 2025 results missed targets. The company maintains a dividend payout with recent $0.1875 declaration.

Outlook remains cautious as revenue declines and margin compression continue, though valuation appears reasonable. Key risks include tariff exposure, competitive pressures, and ongoing revenue contraction. Analyst consensus targets $28.50 with mixed sentiment (27.78% Buy, 61.11% Hold). The stock offers value characteristics but faces fundamental headwinds requiring careful monitoring of turnaround execution.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.

ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HOG

No sentiment data available yet.

ISRG
92% Buy8% Sell
Avg holding period · 84 Days

Top news

Latest headlines on both assets

About Harley-Davidson Inc

Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.

Read more on HOG →

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →